Related Experiment Video
Updated: Aug 7, 2026

A Package of Established Analytical Tools to Investigate the Solid-State Alteration of Lipid-Based Excipients
Published on: August 9, 2022
Analytical techniques for quantification of amorphous/crystalline phases in pharmaceutical solids
Birju Shah1, Vasu Kumar Kakumanu, Arvind K Bansal
1Department of Pharmaceutical Technology (Formulations), National Institute of Pharmaceutical Education and Research (NIPER), SAS Nagar, Punjab, India.
Understanding amorphous systems is key for pharmaceutical formulation. This review details techniques for quantifying amorphous and crystalline phases, aiding in selecting the best method for drug product development and quality control.
Area of Science:
- Pharmaceutical Sciences
- Materials Science
- Analytical Chemistry
Background:
- Pharmaceuticals exist in various solid-state forms, including amorphous, crystalline, solvates, and hydrates.
- Amorphous systems offer unique advantages in drug formulation, influencing drug product properties and biological performance.
- Accurate identification and quantification of solid-state forms are critical for predicting material behavior during storage and handling.
Purpose of the Study:
- To review existing analytical techniques for the quantitative analysis of amorphous and crystalline phases in pharmaceutical materials.
- To provide a compilation of theoretical and practical aspects of these quantification methods.
- To assist formulation scientists in selecting appropriate techniques for amorphous system quantification.
Main Methods:
- Literature review of analytical techniques for amorphous/crystalline phase quantification.
- Discussion of theoretical principles underlying different quantitative methods.
- Evaluation of practical considerations, including accuracy, precision, and suitability.
Main Results:
- Numerous analytical techniques exist for quantifying amorphous/crystalline phases, each with varying properties evaluated.
- Different techniques can yield divergent crystallinity values for the same sample.
- The choice of technique impacts the accuracy, precision, and suitability of the results.
Conclusions:
- Quantitative analysis of physical state is essential for manufacturing and regulatory control of drug products.
- Selecting the appropriate technique is crucial for reliable quantification of amorphous systems.
- This review facilitates informed technique selection for diverse quantification objectives.
More Related Videos
08:55Methods of Ex Situ and In Situ Investigations of Structural Transformations: The Case of Crystallization of Metallic Glasses
Published on: June 7, 2018
13:05Reliable Mechanochemistry: Protocols for Reproducible Outcomes of Neat and Liquid Assisted Ball-mill Grinding Experiments
Published on: January 23, 2018
Related Concept Videos
X-ray Diffraction of Biological Samples
According to Bragg's law, when X-rays strike the sample positioned on a stage, the rays are scattered by the electron clouds around the sample atoms. The X-ray diffraction or scattering is caused by constructive interference of the X-ray waves that reflect off the internal crystal...
Determination of Crystal Structures
Factors Affecting Dissolution: Polymorphism, Amorphism and Pseudopolymorphism
Some polymorphic crystals possess lower aqueous solubility than their amorphous counterparts, leading to incomplete absorption. For instance, the oral suspension of Chloramphenicol, which...
Polymer Classification: Crystallinity
Crystalline domains are the regions where polymer chains are aligned in an orderly manner and held together in proximity by intermolecular forces. For example, chains in the crystalline domains of polyethylene and nylon are bound together by van der Waals...
Crystal Growth: Principles of Crystallization
Initiating crystallization involves manipulating the concentration of the solute and the temperature of the solution. Since crystal growth occurs when the ratio of concentration and solubility of the solute in the solvent – the...
Pharmaceutical Alternatives: Polymorphic Form-Related and Particle Size-Related Therapeutic Nonequivalence